The IMPEDE-PKD and M-FIT trials have been successful in receiving funding via the Medical Research Future Fund (MRFF) rare cancers, rare diseases and unmet needs
Author: aktnadmin
Kidney medication ineffective
A major clinical trial run by the AKTN finds the drug allopurinol does not prevent worsening of kidney disease. University of Queensland researchers at the
Best-Fluids Trial Protocol Published
Is Plasmalyte or Saline best for preventing DGF in kidney transplantation? BEST-Fluids is a pragmatic registry trial that will answer this. Protocol has now been
A time to celebrate
Congratulations to Professor David Johnson and Dr Andrea Viecelli who have been awarded Investigator Grants from the 2020 round.They will begin their research in 2021.
AKTN Celebrates International Clinical Trial Day a little differently in 2020.
The Australasian Kidney Trials Network Team celebrated International Clinical Trials Day on May 20 a little differently this year. With the current social distancing restrictions,